ZYDUS LIFESCIENCES Fact Sheet, ZYDUS LIFESCIENCES Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES Fact Sheet    (CADIL)


Latest: Richa Agarwal's Top 3 Stocks for 2022 Revealed


Here is the latest financial fact sheet of ZYDUS LIFESCIENCES. For more details, see the ZYDUS LIFESCIENCES quarterly results and ZYDUS LIFESCIENCES share price and chart. For a sector overview, read our pharmaceuticals sector report.

ZYDUS LIFESCIENCES Price History

Price Rs 349.1
Mkt Cap Rs m 357,337
Vol '000 55.4
P/E X 15.3
P/CF X 12.5
EPS (TTM) Rs 22.8
1 Day % 1.1
No. of shares m 1,023.74
1 Week % 3.9
1 Month % -4.3
1 Year % -42.9
52 week H/L Rs 668.9/319.4
As on May 17, 2022 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ZYDUS LIFESCIENCES Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
ZYDUS LIFESCIENCES EQUITY SHARE DATA
High Rs460558432352509 
Low Rs305362306207259 
Sales per share (Unadj.) Rs89.7116.3128.6139.2147.5 
Earnings per share (Unadj.) Rs14.517.118.111.520.9 
Diluted earnings per shareRs14.517.118.111.520.9 
Cash flow per share (Unadj.) Rs18.122.323.918.328.0 
Dividends per share (Unadj.) Rs3.203.503.503.503.50 
Adj. dividends per shareRs3.203.503.503.503.50 
Avg Dividend yield %0.80.80.91.30.9 
Book value per share (Unadj.) Rs68.085.4101.5101.4126.9 
Adj. book value per shareRs68.085.4101.5101.4126.9 
Shares outstanding (eoy) m1,023.741,023.741,023.741,023.741,023.74 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x4.34.02.92.02.6 
Avg P/E ratio x26.426.920.424.318.4 
P/CF ratio (eoy) x21.120.615.415.313.7 
Price / Book Value ratio x5.65.43.62.83.0 
Dividend payout %22.120.519.330.516.8 
Avg Mkt Cap Rs m391,582470,666378,171286,034393,092 
No. of employees `000NANANANANA 
Total wages/salary Rs m14,85216,44719,03221,69822,548 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
ZYDUS LIFESCIENCES INCOME DATA
Net Sales Rs m91,807119,050131,656142,531151,022 
Other income Rs m1,4711,3302,0851,171449 
Total revenues Rs m93,278120,380133,741143,702151,471 
Gross profit Rs m19,01228,28629,68024,16631,335 
Depreciation Rs m3,7335,3885,9866,9657,248 
Interest Rs m6311,1081,9583,4181,688 
Profit before tax Rs m16,11923,12023,82114,95422,848 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1,2895,6445,3033,1981,472 
Profit after tax Rs m14,83017,47618,51811,75621,376 
Gross profit margin %20.723.822.517.020.7 
Effective tax rate %8.024.422.321.46.4 
Net profit margin %16.214.714.18.214.2 
ZYDUS LIFESCIENCES BALANCE SHEET DATA
Current assets Rs m60,22382,29784,98187,15487,160 
Current liabilities Rs m53,05860,83073,42582,69478,613 
Net working cap to sales %7.818.08.83.15.7 
Current ratio x1.11.41.21.11.1 
Inventory Days Days4236343533 
Debtors Days Days91981109476 
Net fixed assets Rs m83,02989,110140,147141,183140,943 
Share capital Rs m1,0241,0241,0241,0241,024 
"Free" reserves Rs m68,57686,421102,839102,733128,899 
Net worth Rs m69,60087,445103,863103,757129,923 
Long term debt Rs m24,68425,55139,49732,1466,095 
Total assets Rs m143,252171,407225,128228,337228,103 
Interest coverage x26.521.913.25.414.5 
Debt to equity ratio x0.40.30.40.30 
Sales to assets ratio x0.60.70.60.60.7 
Return on assets %10.810.89.16.610.1 
Return on equity %21.320.017.811.316.5 
Return on capital %17.821.418.013.518.0 
Exports to sales %00000 
Imports to sales %11.89.48.810.210.5 
Exports (fob) Rs m00000 
Imports (cif) Rs m10,87411,24211,59314,50415,911 
Fx inflow Rs m21,28042,68348,40452,75263,535 
Fx outflow Rs m10,87411,24211,59314,50415,911 
Net fx Rs m10,40631,44136,81138,24847,624 
ZYDUS LIFESCIENCES CASH FLOW
From Operations Rs m 13,117 9,193 12,819 29,315 32,930 
From Investments Rs m -28,719 -9,737 -42,387 -10,123 -7,225 
From Financial Activity Rs m 23,158 515 18,846 -15,282 -25,489 
Net Cashflow Rs m 7,556 -29 -8,109 3,989 -905 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 74.9%
Institution 15.4%
Non-Institution 9.7%
Total 100.0%
Free Float 25.1%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2022
 

Company Information

Regd Off Zydus Corporate Park Scheme No.63, Survey No. 536 Khoraj(gandhinagar) Nr. Vaishnodevi Circle, Sarkhej - Gandhinagar Highway, Ahmedabad - 382481
E-mail investor.grievance@zyduscadila.com/dhavalsoni@zyduscadila.com Web www.zyduscadila.com
Tel 079- 26868100 /26868101 /26868102 /26868103-20/71800000 Fax 079- 26862365/48040000
Sector PHARMACEUTICALS Group Cadila Group
Tr Agent Link Intime India Pvt Ltd., 506-508 5th Floor Amaranth Business Complex - I (ABC - I), Beside Gala Business Center St. Xaviers Corner Off C.G. Road, Navrangpura
Auditor Mukesh M. Shah & Co.
CHM: Pankaj R Patel COMP SEC: Dhaval N Soni YEAR OF INC: 1995 BSE CODE: 532321 FV (Rs): 1 DIV YIELD (%): 1.0

Read: CADILA HEALTHCARE 2017-18 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    CIPLA    DR. REDDYS LAB    LUPIN    AUROBINDO PHARMA    

Compare ZYDUS LIFESCIENCES With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    LUPIN    AUROBINDO PHARMA    




Today's Market

4 Reasons Why Sensex Rallied 1,345 Points Today(Closing)

After opening the day higher, Indian share markets extended gains as the session progressed and ended near the day's high.

Views on news

Cadila Healthcare Reports 73% Rise in Profits (Views On News)

May 28, 2021

A look into the company's quarter four financial performance.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

IPO Alert! 3 Companies Including PharmEasy Get the Green Light (Views On News)

Feb 22, 2022

The strong momentum in India's IPO market is poised to continue with the market regulator approving the IPOs of three firms including PharmEasy.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far... (Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022 (Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022 (Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look... (Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better? (Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ZYDUS LIFESCIENCES

  • Track your investment in ZYDUS LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZYDUS LIFESCIENCES

ZYDUS LIFESCIENCES 8-QTR ANALYSIS

COMPARE ZYDUS LIFESCIENCES WITH

MARKET STATS